E.coli Testing Market by Testing Method (Environmental Testing Method, and Clinical Testing Method) End Users (Water and Wastewater Treatment Plants, Government Agencies, Hospitals and Clinics, Diagnostic Laboratories and Others) - Global Outlook & Forecast 2022-2030.
According to the deep-dive market assessment study conducted by Growth + Reports, the global e.coli testing market was pegged at ~ US$1.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2022 to 2030.
One of the key factors driving the market's positive outlook is the rising prevalence of water-borne diseases such as diarrhea and hemolytic uremic syndrome (HUS), as well as the growing global demand for clean potable water. E. coli tests can help monitor the quality of surface and drinking water, which can help prevent the spread of illnesses and diseases. Additionally, the widespread use of the enzyme-substrate test as a presence or absence (P/A) test is also propelling the market growth. These tests are simple to carry out, do not necessitate sophisticated laboratory equipment, and use hydrolyzable fluorogenic substrates to detect the presence of various enzymes produced by bacteria.
However, various technological advancements, such as the development of novel bacterial diagnostic instruments and water testing methods, are fueling the market growth. Other factors, such as rising public health awareness and extensive research and development (R&D) in the field of microbiology, are expected to drive the market even further.
The advanced use of bacterial testing instruments is a major driving force in the global e.coli testing market. Additionally, increased government funding and rapid technological advancement have fueled the growth of this market. The global e.coli testing market is considering an increase in the number of mergers and acquisitions of diagnostic consumables manufacturing companies, as well as rapid product launches.
During the forecast period, the reliability of testing kits is a major challenge for the e.coli testing market. Microscopy, culture, phenotypic and genotypic methods, and nucleic acid amplification are common approaches for identifying microorganisms in food and water. Methods such as matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) (a proteomics method), polymerase chain reaction (PCR), and hybridization-microarrays, which
can detect the expression of thousands of genes at the same time, have improved the accuracy of the results obtained from culturable organisms. However, as part of metagenomic and bioinformatics strategies, next-generation DNA sequencing has helped to broaden sensitivity to a wider range of organisms. One major disadvantage of these second-generation sequencing technologies is their high cost and lengthy sequencing times. As a result, the longer time duration and high costs associated with e.coli testing limit market growth.
Geographically, the global e. coli testing market is dominated by North America. This is due to increased government funding for regional healthcare infrastructure. Furthermore, advancements in e.coli diagnostic procedures have propelled the market in North America. The United States is the largest market in North America for e.coli diagnostic testing, followed by Canada. Germany, France, and the United Kingdom dominate the e.coli diagnostic testing market in Europe. In Asia, the e.coli testing market is also expected to grow rapidly during the forecast period. Testing kits are in high demand in developed countries due to strict government regulations ensuring the safety of drinking water. This is due to various government initiatives to raise awareness about e.coli infections. Furthermore, increased investments by many foreign diagnostic instrument companies have fueled the region's e.coli diagnostic testing market growth. Asia's fastest growing markets for e.coli diagnostic testing are expected to be India, China, and Japan.
Similarly, many pharmaceutical and biotechnology firms adhere to good manufacturing practices (GMP) and current good manufacturing practices (cGMP). The increasing prevalence of infectious diseases is also leading to the detection of e. coli in patient samples. Infectious disease incidence is increasing in developing regions such as the Asia Pacific, the Middle East, Africa, and Latin America. As a result, e. coli testing has increased in diagnostic laboratories and hospitals throughout Asia Pacific regions.
The market's prominent players are increasing their involvement in acquisitions and collaboration activities. These market participants are also involved in product launches, technologically advanced product development, and regulatory approvals. All these strategies are expected to increase expansion opportunities in the e.coli testing market in the coming years.
Some of the prominent players operating in the global e.coli testing market include Meridian Bioscience, Inc., Becton, Dickinson and Company, IDEXX Laboratories, Inc., CPI International, Inc., Pro-Lab Diagnostics, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., BioMerieux Inc., Alere Inc, NanoLogix, Inc.